Pharmacokinetic, efficacy and safety evaluation of B-domain-deleted recombinant FVIII (SCT800) for prophylactic treatment in adolescent and adult patients with severe haemophilia A

Xue, F; Zhao, XL; Sun, J; Zeng, XJ; Yang, FG; Xu, M; Yu, ZQ; Gu, WY; Feng, Y; Li, WQ; Zheng, CC; Bi, H; Xie, LZ; Gai, WL; Yang, RC

Yang, RC (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Expt Hematol, Natl Clin Res Ctr Hematol Disorders, Inst Hematol & Blood Dis Hosp, Tianjin 300020, Peoples R China.

HAEMOPHILIA, 2021; 27 (5): 814

Abstract

Introduction SCT800 is a recombinant human B-domain-deleted coagulation factor VIII (BDDrFVIII) developed in China. Aim To evaluate the repeat pharmac......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索